Global pharmaceutical organization / clinical governance / regulated research
Ensure global study teams, reviewers, and cross-functional stakeholders understand GRCO governance processes and apply submission and review procedures consistently across late-phase oncology trials.
Improved understanding of global governance processes, greater consistency in submission practices, and reduced confusion around committee roles and review pathways.